M Berretta

InstitutionNational Cancer Institute
AddressItaly
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in April 2020
    All Publications
    Bar chart showing 76 publications over 21 distinct years, with a maximum of 15 publications in 2012
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Quagliariello V, D'Aiuto G, Iaffaioli RV, Berretta M, Buccolo S, Iovine M, Paccone A, Cerrone F, Bonanno S, Nunnari G, Laganà N, Botti G, Maurea N. Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctions. Eur Rev Med Pharmacol Sci. 2021 May; 25(10):3898-3907. PMID: 34109598.
      Citations: 2     Fields:    Translation:Humans
    2. Di Franco R, Borzillo V, D'Ippolito E, Scipilliti E, Petito A, Facchini G, Berretta M, Muto P. COVID-19 and radiotherapy: potential new strategies for patients management with hypofractionation and telemedicine. Eur Rev Med Pharmacol Sci. 2020 12; 24(23):12480-12489. PMID: 33336767.
      Citations:    Fields:    Translation:Humans
    3. Berretta M, Facchini G, Fiorica F, Nunnari G, Morra A, Tirelli U. Asymptomatic COVID-19 infection in patients with cancer at a cancer-specialized hospital in Wuhan, China - Preliminary results. Eur Rev Med Pharmacol Sci. 2020 11; 24(21):10924-10925. PMID: 33215469.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    4. Quagliariello V, Bonelli A, Caronna A, Lombari MC, Conforti G, Libutti M, Iaffaioli RV, Berretta M, Botti G, Maurea N. SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications? Eur Rev Med Pharmacol Sci. 2020 09; 24(17):9169-9171. PMID: 32965010.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    5. Ceccarelli M, Nunnari G, Celesia BM, Pellicanò GF, Venanzi Rullo E, Berretta M, Santi Cacopardo B. Editorial - Coronavirus disease 2019 and people living with HIV: clinical considerations. Eur Rev Med Pharmacol Sci. 2020 07; 24(13):7534-7539. PMID: 32706096.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    6. Carta MG, Orrù G, Scano A, Coghe F, Nunnari G, Facchini G, Numis FG, Berretta M. In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention? Eur Rev Med Pharmacol Sci. 2020 04; 24(7):3434-3436. PMID: 32329810.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    7. Diurno F, Numis FG, Porta G, Cirillo F, Maddaluno S, Ragozzino A, De Negri P, Di Gennaro C, Pagano A, Allegorico E, Bressy L, Bosso G, Ferrara A, Serra C, Montisci A, D'Amico M, Schiano Lo Morello S, Di Costanzo G, Tucci AG, Marchetti P, Di Vincenzo U, Sorrentino I, Casciotta A, Fusco M, Buonerba C, Berretta M, Ceccarelli M, Nunnari G, Diessa Y, Cicala S, Facchini G. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur Rev Med Pharmacol Sci. 2020 04; 24(7):4040-4047. PMID: 32329881.
      Citations: 155     Fields:    Translation:HumansCellsPHPublic Health
    8. Ceccarelli M, Berretta M, Venanzi Rullo E, Nunnari G, Cacopardo B, Cacopardo B. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci. 2020 03; 24(5):2781-2783. PMID: 32196628.
      Citations: 56     Fields:    Translation:HumansCells
    9. Perrella A, Carannante N, Berretta M, Rinaldi M, Maturo N, Rinaldi L. Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches? Eur Rev Med Pharmacol Sci. 2020 02; 24(4):2162-2164. PMID: 32141586.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health